Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISION-305: Binodenoson vs Adenosine for Cardiac Stress Imaging
NCT00944970Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of binodenoson in coronary artery disease (CAD), sponsored by Pfizer. Started Oct 2005; status: completed.
02
Drugs
binodenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00944970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944970.